SEC Form 4 · accession 0001127602-19-008349
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | M | 4,365 | $88.05 | A | 24,827 | D | |
| Common Stock | Feb 25, 2019 | M | 3,845 | $109.34 | A | 28,672 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.16 | D | 28,572 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.18 | D | 28,472 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.25 | D | 28,372 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.31 | D | 28,272 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.33 | D | 28,172 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.37 | D | 27,972 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.39 | D | 27,872 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.42 | D | 27,772 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.46 | D | 27,672 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $144.47 | D | 27,272 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.49 | D | 27,072 | D | |
| Common Stock | Feb 25, 2019 | S | 150 | $144.51 | D | 26,922 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.52 | D | 26,822 | D | |
| Common Stock | Feb 25, 2019 | S | 159 | $144.53 | D | 26,663 | D | |
| Common Stock | Feb 25, 2019 | S | 194 | $144.54 | D | 26,469 | D | |
| Common Stock | Feb 25, 2019 | S | 301 | $144.56 | D | 26,168 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $144.60 | D | 25,868 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.62 | D | 25,768 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.63 | D | 25,668 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.66 | D | 25,568 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.69 | D | 25,368 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.705 | D | 25,268 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.74 | D | 25,068 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.77 | D | 24,968 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.79 | D | 24,868 | D | |
| Common Stock | Feb 25, 2019 | S | 6 | $144.82 | D | 24,862 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.87 | D | 24,662 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.88 | D | 24,462 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $88.05 | Feb 25, 2019 | M | 4,365 | D | Feb 24, 2018 | Feb 24, 2022 | Common Stock | 4,365 | 8,731 | D |
| Stock Options (Right to Buy) | $109.34 | Feb 25, 2019 | M | 3,845 | D | Feb 23, 2019 | Feb 23, 2023 | Common Stock | 3,845 | 11,537 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.